MGMT and neoplasm: These prognostic factors can be listed as: age, Karnofsky Performance Score (KPS), recurrence interval, tumor volume, surgery before reirradiation, concurrent systemic therapy, reirradiation dose, and O6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation status [6–12].